about
Many approved drugs have bioactive analogs with different target annotations.Drug-likeness analysis of traditional Chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional Chinese medicinesA rapid identification of hit molecules for target proteins via physico-chemical descriptors.Toward an efficient approach to identify molecular scaffolds possessing selective or promiscuous compounds.DrugMint: a webserver for predicting and designing of drug-like molecules.Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting.Structural diversity and potency range distribution of scaffolds from compounds active against current pharmaceutical targets.Medicinal chemistry for 2020Disease-Specific Differentiation Between Drugs and Non-Drugs Using Principal Component Analysis of Their Molecular Descriptor Space.Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines.Therapeutic target database update 2014: a resource for targeted therapeutics.Computational medicinal chemistry in fragment-based drug discovery: what, how and when.Fragment informatics and computational fragment-based drug design: an overview and update.Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3).Structural and Activity Profile Relationships Between Drug ScaffoldsConformationally Constrained Penta(hetero)cyclic Molecular Architectures via Photoassisted Diversity-Oriented Synthesis.Fragment-based QSAR strategies in drug design.Anthropogenic reaction parameters--the missing link between chemical intuition and the available chemical space.Synthesis and in vitro biological evaluation of novel diaminothiophene scaffolds as antitumor and anti-influenza virus agents. Part 2Prediction Methods of Herbal Compounds in Chinese Medicinal Herbs
P2860
Q30581583-D06ACE57-2213-4CE9-8373-B6AEDC5A87FCQ34556232-ACC1115B-1D4F-4787-BD9E-555C0A0E7B8BQ34707166-6D07A2BF-54AC-462E-9D04-6BAF402E4B6FQ34713826-8EC82D9C-B104-43EC-B2AA-A9D59C0E7349Q35031360-6A4935A2-BCB0-4D06-BA29-B7584D33D074Q35149474-5387ADBB-31B3-4F13-8DAC-B38FE9550265Q35562106-5FE04D5D-A6DE-4A58-A942-9DE53198EE8BQ35593223-DDCCF816-F87E-406E-AD2F-F6F91E11FA8FQ36091270-900DE438-C457-47FA-869B-101D6F402EF9Q36513179-AFFA51C6-3E5B-4A68-B82F-C635A742A52CQ37661746-69CDB9D3-0FCD-4397-8AA8-3C1C834075B2Q37856296-97FEBE4D-D579-438A-935B-3060E92D7256Q37995087-DA1187A4-54B0-4750-AC76-3FFC557AEC5AQ39523484-D30C3E26-6312-4EE4-B553-FF6CC8CC935DQ39886028-970ADD5E-4C7D-4DAB-A202-683013F5DEC0Q42424568-1FCA475D-C72D-435B-B70E-1DF0E44A682FQ43539084-84F7F83B-8F88-4D6E-A2CD-C6049F11C7D0Q47217511-AA6E1D36-D99D-4B22-94A4-E8DFE8883359Q58594050-521A2BAE-44A5-47AE-B9EA-EE7C56E23F57Q58696501-5671019B-BBD3-4D87-A44C-08C9E22C47CC
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Drug and drug candidate building block analysis.
@ast
Drug and drug candidate building block analysis.
@en
Drug and drug candidate building block analysis.
@nl
type
label
Drug and drug candidate building block analysis.
@ast
Drug and drug candidate building block analysis.
@en
Drug and drug candidate building block analysis.
@nl
prefLabel
Drug and drug candidate building block analysis.
@ast
Drug and drug candidate building block analysis.
@en
Drug and drug candidate building block analysis.
@nl
P356
P1476
Drug and drug candidate building block analysis.
@en
P356
10.1021/CI900398F
P577
2010-01-01T00:00:00Z